Institutional Ownership Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX). We have compiled data on the 1,717 institutions that hold shares in the stock, with a total of 226 Million shares, which have been reported (via 13F filing form) to have a value of $117 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Capital World Investors
Los Angeles, CA |
Aug 13, 2024 Q2 2024 |
26,707,966
shares
|
$13.8 Billion
2.1% of portfolio
|
Q2 2024
Added 4.46%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
22,975,521
shares
|
$11.9 Billion
0.21% of portfolio
|
Q2 2024
Added 1.32%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,312,244
shares
|
$11 Billion
0.23% of portfolio
|
Q2 2024
Reduced 2.95%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
11,726,076
shares
|
$6.06 Billion
0.24% of portfolio
|
Q2 2024
Reduced 2.34%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Aug 13, 2024 Q2 2024 |
8,539,339
shares
|
$4.41 Billion
0.9% of portfolio
|
Q2 2024
Added 48.67%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2024 Q2 2024 |
7,221,072
shares
|
$3.73 Billion
1.22% of portfolio
|
Q2 2024
Added 1.74%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
6,928,587
shares
|
$3.58 Billion
0.26% of portfolio
|
Q3 2024
Added 4.98%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
6,325,308
shares
|
$3.27 Billion
0.26% of portfolio
|
Q2 2024
Added 8.81%
|
|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
5,550,386
shares
|
$2.87 Billion
1.61% of portfolio
|
Q3 2024
Added 18.11%
|
|
|
Wellington Management Group LLP
Boston, MA |
Aug 13, 2024 Q2 2024 |
4,094,449
shares
|
$2.12 Billion
0.35% of portfolio
|
Q2 2024
Reduced 10.17%
|
|
|
Amundi
Paris, I0 |
Aug 14, 2024 Q2 2024 |
3,504,059
shares
|
$1.81 Billion
0.65% of portfolio
|
Q2 2024
Reduced 2.21%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 14, 2024 Q2 2024 |
3,429,086
shares
|
$1.77 Billion
0.25% of portfolio
|
Q2 2023
Reduced 23.92%
|
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
3,258,628
shares
|
$1.68 Billion
0.12% of portfolio
|
Q2 2024
Added 2.33%
|
|
|
Loomis Sayles & CO L P
|
Aug 13, 2024 Q2 2024 |
3,142,171
shares
|
$1.62 Billion
2.03% of portfolio
|
Q2 2024
Added 1.02%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Aug 09, 2024 Q2 2024 |
2,746,012
shares
|
$1.42 Billion
0.41% of portfolio
|
Q2 2024
Reduced 2.07%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 13, 2024 Q2 2024 |
2,584,327
shares
|
$1.34 Billion
0.35% of portfolio
|
Q2 2024
Added 5.65%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
2,572,485
shares
|
$1.33 Billion
0.11% of portfolio
|
Q2 2024
Added 1.09%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
2,533,904
shares
|
$1.31 Billion
0.2% of portfolio
|
Q2 2024
Reduced 1.73%
|
|
|
Legal & General Group PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
2,422,677
shares
|
$1.25 Billion
0.26% of portfolio
|
Q2 2024
Added 1.22%
|
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
2,416,717
shares
|
$1.25 Billion
0.62% of portfolio
|
Q2 2024
Reduced 6.49%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2024 Q2 2024 |
2,211,674
shares
|
$1.14 Billion
0.12% of portfolio
|
Q2 2024
Reduced 50.78%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Aug 27, 2024 Q2 2024 |
2,090,704
shares
|
$1.08 Billion
0.82% of portfolio
|
Q2 2024
Reduced 13.91%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
2,062,499
shares
|
$1.07 Billion
0.17% of portfolio
|
Q2 2024
Added 47.22%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2024 Q2 2024 |
2,054,781
shares
|
$1.06 Billion
0.26% of portfolio
|
Q2 2024
Reduced 7.66%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2024 Q2 2024 |
1,802,742
shares
|
$932 Million
0.18% of portfolio
|
Q2 2024
Reduced 13.79%
|